Literature DB >> 9443771

Effects of PTH(1-34) on blood pressure, renal function, and hormones in essential hypertension: the altered pattern of reactivity may counteract raised blood pressure.

B Jespersen1, A Randløv, J Abrahamsen, N Fogh-Andersen, I L Kanstrup.   

Abstract

As it has been suggested that parathyroid hormone (PTH) is implicated in the pathophysiology of essential hypertension, the effects of PTH(1-34) were assessed during infusion over 120 min in ten men with essential hypertension and in ten healthy men. Ionized calcium was kept constant by a clamping technique. Mean arterial blood pressure fell slightly in the patients (116 mm Hg, median, before, and 108 mm Hg during the infusion, P < .01), but remained unchanged in the controls (median 87 mm Hg). The pulse rate rose to a similar extent in the two groups, but cardiac output, measured by the CO2 rebreathing technique, was unchanged. The glomerular filtration rate (GFR) was slightly lower in the hypertensives than in the controls at baseline (92 v 109 mL/min, P < .02), but it increased similarly during PTH infusion in both groups (+13% v +9%, medians), as did the effective renal plasma flow (+50% v +38%). The urinary rate of sodium excretion, which was similar at baseline, increased more in the patients than in the controls (+191% v +46%, P < .05); this was mainly attributable to a reduction in the tubular reabsorption of sodium. Calculations based on lithium clearance indicated that mainly the proximal tubular reabsorption of sodium decreased during PTH infusion. Baseline plasma PTH(1-84) was higher in the patients than in the controls (20.5 ng/L v 16.5 ng/L, P < .05). The baseline plasma values of renin, aldosterone, atrial natriuretic peptide, endothelin, and noradrenaline were similar in the two groups. During infusion of PTH, renin increased less in the patients than in the controls (P < .02), and aldosterone increased only in the controls (P < .01). The other hormonal values remained unchanged. In conclusion, the patients with essential hypertension had increased baseline PTH values, but nevertheless PTH had more marked vasodilative and natriuretic effects than in the controls. PTH thus seems to counteract rather than aggravate elevation of blood pressure in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9443771     DOI: 10.1016/s0895-7061(97)00275-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  7 in total

1.  Elevation of parathyroid hormone levels in atrial fibrillation.

Authors:  Michiel Rienstra; Steven A Lubitz; Michael L Zhang; Rebecca R Cooper; Patrick T Ellinor
Journal:  J Am Coll Cardiol       Date:  2011-06-21       Impact factor: 24.094

2.  The relationship between blood pressure and serum parathyroid hormone with special reference to urinary calcium excretion: the Tromsø study.

Authors:  F Saleh; R Jorde; J Svartberg; J Sundsfjord
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

3.  Hyponatremia and osteoporosis: insights from the Danish National Patient Registry.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  Osteoporos Int       Date:  2014-12-03       Impact factor: 4.507

4.  Parathyroidectomy decreases systolic and diastolic blood pressure in hypertensive patients with primary hyperparathyroidism.

Authors:  Aliya Heyliger; Vin Tangpricha; Collin Weber; Jyotirmay Sharma
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

5.  Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis.

Authors:  Cortney Bosworth; Michael C Sachs; Daniel Duprez; Andrew N Hoofnagle; Joachim H Ix; David R Jacobs; Carmen A Peralta; David S Siscovick; Bryan Kestenbaum; Ian H de Boer
Journal:  Clin Endocrinol (Oxf)       Date:  2013-05-20       Impact factor: 3.478

6.  Parathyroid Hormone's Acute Effect on Vasodilatory Function.

Authors:  P Farahnak; L Lind; K Mattala; I-L Nilsson
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2010-04-26

7.  Long-term renal graft outcome after parathyroidectomy - a retrospective single centre study.

Authors:  Margret Patecki; Irina Scheffner; Hermann Haller; Wilfried Gwinner
Journal:  BMC Nephrol       Date:  2020-02-18       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.